6505--Zirabev (bevacizumab-bvzr) Effective 8/13/2020 - 8/12/2021
Award Notice Posted
- Solicitation number
- 36E79720R0038
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Pfizer Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79720D0047 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Veterans Affairs National Acquisition Center awards contract 36E79720D0047 to Pfizer Inc. for the supply of 413,511,134.20 units of the drug Zirabev (bevacizumab-bvzr) effective from August 13, 2020 through August 12, 2021. The contract was awarded on July 13, 2020 under solicitation 36E79720R0038 for a total value of $41,351,134.20 to Pfizer located at 235 E 42nd Street, New York, NY 10017.
Notice text
Awarded contract 36E79720D0047 to PFIZER INC. for 41351134.20000000 on 2020-07-13.
Files
| File | Type | Posted |
|---|---|---|
| 36E79720D0047_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| 6505--Bevacizumab | Solicitation | |
| 6505--Bevacizumab | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity